₹46
(Inclusive of all Taxes)
₹6.9 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
निर्माता/विपणक :
अज़िलियन हेल्थकेयर
उपभोग प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Wilspas P Oral Suspension:
Co-administration of Wilspas P Oral Suspension with Meloxicam together can increase the risk or severity of bleeding.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Meloxicam together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking a doctor.
Co-administration of Wilspas P Oral Suspension with Meloxicam together can increase the risk or severity of bleeding.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Meloxicam together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking a doctor.
Critical
How does the drug interact with Wilspas P Oral Suspension:
Coadministration of Wilspas P Oral Suspension with Ketorolac can increase the risk or severity of gastric bleeding and ulcers.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Ketorolac together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Wilspas P Oral Suspension with Ketorolac can increase the risk or severity of gastric bleeding and ulcers.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Ketorolac together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Wilspas P Oral Suspension:
Co-administration of Wilspas P Oral Suspension with Prasugrel can increase the risk or severity of gastric bleeding, ulceration, and rarely, perforation leading to serious blood loss.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Prasugrel together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Co-administration of Wilspas P Oral Suspension with Prasugrel can increase the risk or severity of gastric bleeding, ulceration, and rarely, perforation leading to serious blood loss.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Prasugrel together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Wilspas P Oral Suspension:
Teriflunomide may cause liver damage and taking it with Wilspas P Oral Suspension may increase that risk.
How to manage the interaction:
Although taking Wilspas P Oral Suspension and Teriflunomide together can cause an interaction, it can be taken if your doctor has suggested it. If you have any of these symptoms, it's important to contact your doctor right away - liver problems, fever, feeling cold, pain in your joints, swelling, bruises, rash, itchy skin, not feeling hungry, feeling tired, feeling sick, throwing up, dark urine, or bleeding. Do not discontinue any medications without consulting a doctor.
Teriflunomide may cause liver damage and taking it with Wilspas P Oral Suspension may increase that risk.
How to manage the interaction:
Although taking Wilspas P Oral Suspension and Teriflunomide together can cause an interaction, it can be taken if your doctor has suggested it. If you have any of these symptoms, it's important to contact your doctor right away - liver problems, fever, feeling cold, pain in your joints, swelling, bruises, rash, itchy skin, not feeling hungry, feeling tired, feeling sick, throwing up, dark urine, or bleeding. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Wilspas P Oral Suspension:
Coadministration of Wilspas P Oral Suspension with Tenofovir disoproxil can show additive effect and increase the risk or severity of kidney problems.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Tenofovir Disoproxil together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, dizziness, red or black tarry stools, vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Wilspas P Oral Suspension with Tenofovir disoproxil can show additive effect and increase the risk or severity of kidney problems.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Tenofovir Disoproxil together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, dizziness, red or black tarry stools, vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Wilspas P Oral Suspension:
Coadministration of Wilspas P Oral Suspension with Dabigatran can increase the risk or severity of bleeding leading to serious blood loss.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Dabigatran etexilate together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Wilspas P Oral Suspension with Dabigatran can increase the risk or severity of bleeding leading to serious blood loss.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Dabigatran etexilate together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Wilspas P Oral Suspension:
Taking Human immunoglobulin with Wilspas P Oral Suspension, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and Wilspas P Oral Suspension, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Taking Human immunoglobulin with Wilspas P Oral Suspension, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and Wilspas P Oral Suspension, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Wilspas P Oral Suspension:
Coadministration of Wilspas P Oral Suspension with Deferasirox can increase the risk or severity of gastric bleeding.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Deferasirox together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any symptoms of increased or decreased urination, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Wilspas P Oral Suspension with Deferasirox can increase the risk or severity of gastric bleeding.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Deferasirox together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any symptoms of increased or decreased urination, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Wilspas P Oral Suspension:
Using Wilspas P Oral Suspension and baricitinib together may increase the risk of gastrointestinal perforation (a serious health condition where a hole develops through the stomach or intestine).
How to manage the interaction:
Co-administration of Wilspas P Oral Suspension with Baricitinib can result in an interaction, but it can be taken if your doctor has advised it. If you notice any signs like severe stomach pain, fever, or vomiting, consult a doctor. Do not stop using any medications without talking to a doctor.
Using Wilspas P Oral Suspension and baricitinib together may increase the risk of gastrointestinal perforation (a serious health condition where a hole develops through the stomach or intestine).
How to manage the interaction:
Co-administration of Wilspas P Oral Suspension with Baricitinib can result in an interaction, but it can be taken if your doctor has advised it. If you notice any signs like severe stomach pain, fever, or vomiting, consult a doctor. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Wilspas P Oral Suspension:
Co-administration of Wilspas P Oral Suspension with Ibrutinib can increase the risk or severity of bleeding, leading to serious blood loss.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Ibrutinib together can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any symptoms of unusual bleeding or bruising, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Co-administration of Wilspas P Oral Suspension with Ibrutinib can increase the risk or severity of bleeding, leading to serious blood loss.
How to manage the interaction:
Taking Wilspas P Oral Suspension with Ibrutinib together can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any symptoms of unusual bleeding or bruising, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
शराब
Unsafe
विल्स्पैस पी ओरल सस्पेंशन लेते समय शराब का सेवन न करें क्योंकि इससे चक्कर आने की समस्या बढ़ सकती है। इससे पेट से खून बहने का खतरा भी बढ़ सकता है।
गर्भावस्था
Caution
यदि आप गर्भवती हैं या आपको इस संबंध में कोई चिंता है तो कृपया अपने डॉक्टर से परामर्श करें; आपका डॉक्टर केवल तभी दवा लिखेगा जब लाभ जोखिम से अधिक होंगे।
स्तनपान
Caution
कृपया विल्स्पैस पी ओरल सस्पेंशन लेने से पहले अपने चिकित्सक से परामर्श करें; आपका डॉक्टर यह तय करेगा कि स्तनपान कराने वाली माताओं द्वारा विल्स्पैस पी ओरल सस्पेंशन लिया जा सकता है या नहीं।
ड्राइविंग
Caution
विल्स्पैस पी ओरल सस्पेंशन से चक्कर आ सकता है। जब तक आप सतर्क न हों, गाड़ी न चलाएं या मशीनरी न चलाएं।
जिगर
Caution
लीवर की खराबी वाले मरीजों में खुराक समायोजन की आवश्यकता हो सकती है। अगर आपको लीवर की समस्या है या इस बारे में कोई चिंता है तो कृपया अपने डॉक्टर से परामर्श करें।
किडनी
Caution
गुर्दे की खराबी वाले रोगियों में खुराक समायोजन की आवश्यकता हो सकती है। अगर आपको गुर्दे की समस्या है या इस बारे में कोई चिंता है तो कृपया अपने डॉक्टर से परामर्श करें।
बच्चे
Caution
कृपया अपने डॉक्टर से परामर्श करें। आपका डॉक्टर आपके बच्चे की स्थिति के आधार पर खुराक और अवधि निर्धारित करेगा।
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
